Fund HoldingsSarissa Capital Management LP

Total Portfolio Value
$648.90M
Total Bought
$51.41M
Total Sold
$197.95M
Net Transaction
-$146.54M
Filing Period:
Securities
SharesValue ($K)
Q3 2023
Q4 2023
Change
Q3 2023
Q4 2023
Weight (%)
Change
IRONWOOD PHARMACEUTICALS INC16,390,00016,390,0000157,836187,50228.90%+29,666
INNOVIVA INC(INVA)7,277,0007,277,000094,528116,72317.99%+22,195
NEUROCRINE BIOSCIENCES INC(NBIX)366,000470,000+104,00041,17561,9279.54%+20,752
GILEAD SCIENCES INC(GILD)920,4001,075,400+155,00068,97587,11813.43%+18,143
AMARIN CORP PLC10,442,45324,850,623+14,408,1709,60721,6203.33%+12,013
BIOGEN INC(BIIB)643,000643,0000165,257166,38925.64%+1,132
BIOCRYST PHARMACEUTICALS INC(BCRX)775,0001,000,000+225,0005,4875,9900.92%+503
VOR BIOPHARMA INC(VOR)618,000618,00001,3101,3910.21%+80
REGULUS THERAPEUTICS INC185,183185,18302542370.04%-17
MERSANA THERAPEUTICS INC550,0000-550,0006990-698
ALKERMES PLC(ALKS)7,042,2000-7,042,200197,2520-197,252
Page 1 of 1